38 results match your criteria: "Mayo Clinic in Scottsdale[Affiliation]"
Mov Disord
August 2023
Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, Arizona, USA.
PEC Innov
December 2022
Department of Urology, The Mayo Clinic in Scottsdale, Scottsdale, AZ, USA.
Objective: To investigate comfort level and preferences of automated reminder systems (mail, email, text message, phone call, patient-portal message, and/or smartphone application) to promote adherence to recommended therapies for patients seeking care for urinary incontinence (UI) at our urology clinic in Phoenix, Arizona.
Methods: Anonymous surveys were distributed in English to adult patients with UI from 4/2019-5/2019. Patient demographics, UI type, and access to and use of the Internet, smartphone and patient-portal were assessed.
Innov Clin Neurosci
January 2022
Drs. Hasan, Adler, Mehta, and Driver-Dunckley are with the Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic in Scottsdale, Arizona.
Objective: Measuring olfactory dysfunction shows promise as one of a number of nonmotor biomarkers that can be used to detect clinically manifest and prodromal Parkinson's disease (PD) and dementia with Lewy bodies (DLB) and to differentiate these from nonsynucleinopathies. Using a larger sample size than in our previous study, we evaluated the relationship between olfactory dysfunction based on the University of Pennsylvania Smell Identification Test (UPSIT) to the clinicopathological findings in patients with PD (n=41), patients with incidental Lewy body disease (ILBD) (n=47), and controls with no neurodegenerative disease (n=137).
Design: This study was conducted through the Arizona Study of Aging and Neurodegenerative Disease (AZSAND).
JAAPA
May 2022
Sagar B. Dugani practices in the Division of Hospital Internal Medicine and the Division of Health Care Delivery Research, Kern Center for the Science of Health Care Delivery, at the Mayo Clinic in Rochester, Minn. Karen M. Fischer is a biostatistician in the Department of Quantitative Health Sciences at the Mayo Clinic in Rochester, Minn. Holly L. Geyer practices in the Division of Hospital Internal Medicine at the Mayo Clinic in Scottsdale, Ariz. Michael J. Maniaci practices in the Division of Hospital Internal Medicine, Mayo Clinic in Jacksonville, Fla. Ivana T. Croghan practices in the Department of Medicine, Division of General Internal Medicine, the Kern Center for the Science of Health Care Delivery, and the Department of Medicine's Clinical Research Office, all at the Mayo Clinic in Rochester, Minn. M. Caroline Burton practices in the Division of Hospital Internal Medicine at the Mayo Clinic in Rochester, Minn. Dr. Dugani discloses that he is supported by the National Institutes of Health/National Institute on Minority Health and Health Disparities (NIH K23 MD016230) and the Robert and Elizabeth Strickland Career Development Award at the Mayo Clinic in Rochester, Minn. This publication was made possible by the Mayo Clinic CTSA through grant number UL1TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The findings do not necessarily represent the views of the funders. The authors have disclosed no other potential conflicts of interest, financial or otherwise.
Objectives: Hospitalists, comprising PAs, NPs, and physicians, manage patients hospitalized with COVID-19. To guide the development of support programs, this study compared the psychologic wellness of hospitalist PAs, NPs, and physicians during the COVID-19 pandemic.
Methods: We surveyed hospitalists in 16 hospitals at Mayo Clinic, from May 4 to 25, 2020.
JAAPA
December 2021
Simone T. Jensen practices at the Mayo Clinic in Scottsdale, Ariz. The author has disclosed no potential conflicts of interest, financial or otherwise.
Although humor in health care can facilitate relationship building between patients and clinicians, callous humor used to deflect or dismiss distressing emotions undermines relationships, erodes trust, and expresses disregard for vulnerability. Because it affects collegiality, training, and patient care, callous humor should not be tolerated, especially when directed at patients. This article considers why it is important to respond to colleagues who make callous jokes and suggests how to do so.
View Article and Find Full Text PDFInnov Clin Neurosci
September 2019
Drs. Driver-Dunckley, Mehta, and Adler are with the Department of Neurology of the Parkinson's Disease and Movement Disorders Center at the Mayo Clinic in Scottsdale, Arizona. Zhang is with the Section of Biostatistics at the Mayo Clinic in Scottsdale, Arizona. Shill is with the Barrow Neurological Institute in Phoenix, Arizona. Belden, Zamrini, Davis, and Beach are with the Banner Sun Health Research Institute in Sun City, Arizona.
The Movement Disorder Society's Unified Parkinson's Disease Rating Scale (MDSUPDRS), Scales for Outcomes in Parkinson's Disease-Autonomic (SCOPA-AUT), Mayo Sleep Questionnaire, Epworth Sleepiness Scale, and Neuropsychiatric Inventory Questionnaire (NPI-Q) are validated instruments for assessing signs and symptoms of Parkinson's disease (PD). We sought to determine whether responses on the MDS-UPDRS correlate with responses to other scales used in patients with PD. Study subjects were enrolled in the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND).
View Article and Find Full Text PDFDecision making on behalf of an incapacitated patient is challenging, particularly in the context of venoarterial extracorporeal membrane oxygenation (VA-ECMO), a medically complex, high-risk, and costly intervention that provides cardiopulmonary support. In the absence of a surrogate and an advance directive, the clinical team must make decisions for such patients. Because states vary in terms of which decisions clinicians can make, particularly at the end of life, the legal landscape is complicated.
View Article and Find Full Text PDFJ Law Med Ethics
March 2018
Susan M. Wolf, J.D., is McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre Baker Daniels Professor of Law; Professor of Medicine; and Chair of the Consortium on Law and Values in Health, Environment & the Life Sciences, University of Minnesota. She was one of three Principal Investigators on NIH/NCI/NHGRI grant 1R01CA154517 on return of genomic results to family members, including after the death of the proband. Emily Scholtes, J.D., is a graduate of the University of Minnesota Law School, where she served as a Research Assistant on the project on return of genomic results to family members. She then clerked for the U.S. Court of Appeals for the Eighth Circuit before going into private practice. The views expressed in this article are exclusively those of the authors. This article has been prepared for informational purposes only and does not constitute legal advice. Barbara A. Koenig, Ph.D., is Director of Bioethics and Professor of Bioethics and Medical Anthropology based at the Institute for Health & Aging, University of California, San Francisco. She was one of three Principal Investigators on NIH/NCI/NHGRI grant 1R01CA154517 on return of genomic results to family members, including after the death of the proband. Gloria M. Petersen, Ph.D., is Professor of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine. She is a Founding Fellow of the American College of Medical Genetics and Genomics. She was one of three Principal Investigators on NIH/NCI/NHGRI grant 1R01CA154517 on return of genomic results to family members, including after the death of the proband. Susan A. Berry, M.D., is Professor of Pediatrics & Genetics and Division Director for Genetics and Metabolism in the Department of Pediatrics, University of Minnesota. She is a Fellow of the American Academy of Pediatrics and the American College of Medical Genetics. Laura M. Beskow, M.P.H., Ph.D., is Professor of Health Policy and Director of Research Ethics, Center for Biomedical Ethics & Society, Vanderbilt University. She received her M.P.H. with a concentration in health law from Boston University and her Ph.D. in Health Policy and Administration, with a minor in Epidemiology, at the University of North Carolina at Chapel Hill. Mary B. Daly, M.D., Ph.D., is a medical oncologist and epidemiologist who chairs the Department of Clinical Genetics at Fox Chase Cancer Center. Her research focuses on defining the best methods of communicating hereditary cancer risk information and on providing risk management strategies and coping skills to family members dealing with an increased risk for cancer. Conrad V. Fernandez, B.Sc., M.D., is Professor and Head of the Division of Pediatric Hematology/Oncology in the Department of Pediatrics, IWK Health Centre, Dalhousie University and is cross-appointed in Bioethics, Medicine, and Postgraduate Studies. He obtained his medical degree at McMaster University, specialist certification in Pediatrics as a Fellow of the Royal College of Physicians and Surgeons of Canada at Dalhousie University, and completed specialty training in Pediatric Hematology/Oncology at the University of British Columbia. Robert C. Green, M.D., M.P.H., is a medical geneticist and physician-scientist who directs the G2P Research Program in translational genomics and health outcomes in the Division of Genetics, Brigham and Women's Hospital and Harvard Medical School. He is also Associate Director for Research at Partners Personalized Medicine. Dr. Green leads and co-leads the MedSeq Project and the BabySeq Project respectively, two NIH-funded randomized trials designed to explore the medical, behavioral, and economic implications of integrating genome sequencing into the medical care of adults and newborns. Bonnie S. LeRoy, M.S., C.G.C., is Professor and Director of the Graduate Program in Genetic Counseling, University of Minnesota. Her work focuses on preparing graduate students to enter the profession of genetic counseling. Her research examines the ethical and social challenges associated with the genetic counseling profession. She served as the President of the American Board of Genetic Counseling from 2001-03. Noralane M. Lindor, M.D., is Professor of Medical Genetics in the Department of Health Sciences Research at Mayo Clinic in Scottsdale, Arizona. She received her medical degree from Mayo Medical School, and did her residencies at Bowman Gray School of Medicine in Winston-Salem, North Carolina, and at Mayo Clinic in Rochester. P. Pearl O'Rourke, M.D., is Director of Human Research Affairs at Partners HealthCare in Boston, and Associate Professor of Pediatrics at Harvard Medical School. She completed medical school at Dartmouth Medical School and the University of Minnesota Medical School. Carmen Radecki Breitkopf, Ph.D., is Professor of Health Services Research in the Department of Health Sciences Research at Mayo Clinic College of Medicine and Science in Rochester, Minnesota. She earned her Master's and Doctoral degrees in Psychology from the State University of New York at Albany. Mark A. Rothstein, J.D., is Herbert F. Boehl Chair of Law & Medicine and Director of the Institute for Bioethics, Health Policy & Law at the University of Louisville School of Medicine. He is past-President of the American Society of Law, Medicine & Ethics and serves as Public Health Ethics editor for the American Journal of Public Health. Brian Van Ness, Ph.D., is Professor of Genetics, Cell Biology and Development at the University of Minnesota. He earned his doctorate in Biochemistry from the University of Minnesota, completed a postdoctoral fellowship at Fox Chase Cancer Center, and has served as the Department Head and Director of the Institute of Human Genetics at the University of Minnesota. Benjamin S. Wilfond, M.D., is Director of the Treuman Katz Center for Pediatric Bioethics, Seattle Children's Hospital; Professor and Chief of the Division of Bioethics; Professor, Pulmonary and Sleep Medicine, Department of Pediatrics; and Adjunct Professor, Department of Bioethics and Humanities, University of Washington School of Medicine. He is past-President of the Association of Bioethics Program Directors, Chair for the Clinical Research Ethics Consultation Working Group for the Clinical and Translational Science Awards program, and a member of the Bioethics and Legal Working Group of the Newborn Screening Translational Research Network.
Introduction: Acute cerebral injuries, such as cerebral ischemic or hemorrhagic events, have been repeatedly correlated with sudden electrocardiogram (ECG) changes, such as cardiac arrhythmias, QT prolongation, and T-wave inversion (the "cerebral T-wave"). Injuries to the insular cortex have been reported in the literature to result in such changes, possibly due to increased sympathetic tone to the cardiac system.
Case Report: A 65-year-old gentleman presented with an acute right middle cerebral artery territory infarction, and was found to have ECG abnormalities and left ventricular dysfunction, which improved after the acute phase of the stroke.
Am J Nurs
March 2018
Jennifer Ernst is a clinical nurse specialist in the Department of Nursing at the Mayo Clinic in Scottsdale, AZ, where Catherine R. Yows is a nurse administrator. Christine D. Aliory is an RN in the Department of Nursing at the Mayo Clinic Hospital in Phoenix. The authors wish to thank Michelle A. Larson, DNP, RN, NE-BC, for assistance with data analysis and Jenifer M. Hart, RN, PCCN, for assistance with data mining. Contact author: Jennifer Ernst, The authors have disclosed no potential conflicts of interest, financial or otherwise.
: The competing demands of caring for high-acuity patients, reducing health care costs, and improving access to specialty care are complex challenges facing all health care providers. One approach-empowering nurses to expand their scope of practice-has been successfully employed for two decades by the nurse and physician leadership of a neurology department in an urban academic medical center. This article discusses the department's implementation of a quality improvement initiative to enhance access to neurology services in an ambulatory clinic by extending nursing practice to include lumbar puncture.
View Article and Find Full Text PDFGastroenterol Hepatol (N Y)
October 2017
Ms Parrish is a nutrition support specialist at the University of Virginia Health System's Digestive Health Center in Charlottesville, Virginia. Dr DiBaise is a professor of medicine in the Division of Gastroenterology and Hepatology at the Mayo Clinic in Scottsdale, Arizona.
Short bowel syndrome (SBS) is a malabsorptive disorder associated with significant morbidity and mortality, reduced quality of life, and high health care costs. Managing the patient with SBS requires an understanding of gastrointestinal anatomy and physiology; a dedicated multidisciplinary team; and the coordination of dietary, fluid, pharmacologic, and comorbid disease management. This article provides an overview of the current state of management of SBS, including a practical approach to optimizing the care and quality of life of the adult patient with SBS.
View Article and Find Full Text PDFGastroenterol Hepatol (N Y)
February 2017
Capsule endoscopy is the diagnostic test of choice for the evaluation of overt and occult small bowel bleeding. Its yield is higher in patients presenting with overt bleeding. The yield is also improved if the capsule is performed soon after the presentation of bleeding.
View Article and Find Full Text PDFAbdom Radiol (NY)
June 2016
Departments of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.
Hereditary forms of kidney carcinoma account for 5-8% of all malignant kidney neoplasms. The renal tumors are often multiple and bilateral and occur at an earlier age. Each of the hereditary kidney carcinoma syndromes is associated with specific gene mutations as well as a specific histologic type of kidney carcinoma.
View Article and Find Full Text PDFJ Law Med Ethics
January 2017
Professor of Bioethics and Medical Anthropology based at the Institute for Health & Aging, University of California, San Francisco. Currently, she co-directs a Center of Excellence in ELSI Research that focuses on translational genomics, co-leads an NCI/NHGRI R01 on return of results in genomic biobanks, and directs the ELSI component of a U19 award focused on newborn screening in an era of whole genome analysis.
Data are lacking with regard to participants' perspectives on return of genetic research results to relatives, including after the participant's death. This paper reports descriptive results from 3,630 survey respondents: 464 participants in a pancreatic cancer biobank, 1,439 family registry participants, and 1,727 healthy individuals. Our findings indicate that most participants would feel obligated to share their results with blood relatives while alive and would want results to be shared with relatives after their death.
View Article and Find Full Text PDFJ Law Med Ethics
January 2017
Director of the Treuman Katz Center for Pediatric Bioethics, Seattle Children's Hospital; Professor and Chief of the Division of Bioethics; Professor, Pulmonary and Sleep Medicine, Department of Pediatrics; and Adjunct Professor, Department of Bioethics and Humanities, University of Washington School of Medicine. He is President of the Association of Bioethics Program Directors, Chair for the Clinical Research Ethics Consultation Working Group for the Clinical and Translational Science Awards program, and a member of the Bioethics and Legal Working Group of the Newborn Screening Translational Research Network.
Genomic research results and incidental findings with health implications for a research participant are of potential interest not only to the participant, but also to the participant's family. Yet investigators lack guidance on return of results to relatives, including after the participant's death. In this paper, a national working group offers consensus analysis and recommendations, including an ethical framework to guide investigators in managing this challenging issue, before and after the participant's death.
View Article and Find Full Text PDFStrictures of the bile duct are a well-recognized complication of liver transplant and account for more than 50% of all biliary complications after deceased donor liver transplant and living donor liver transplant. Biliary strictures that develop after transplant are classified as anastomotic strictures or nonanastomotic strictures, depending on their location in the bile duct. The incidence, etiology, natural history, and response to therapy of the 2 types vary greatly, so their distinction is clinically important.
View Article and Find Full Text PDFGastroenterol Hepatol (N Y)
May 2014
Dr Foxx-Orenstein is an associate professor, Dr Umar is an assistant professor, and Dr Crowell is a professor in the Division of Gastroenterology at the Mayo Clinic in Scottsdale, Arizona.
Anorectal disorders result in many visits to healthcare specialists. These disorders include benign conditions such as hemorrhoids to more serious conditions such as malignancy; thus, it is important for the clinician to be familiar with these disorders as well as know how to conduct an appropriate history and physical examination. This article reviews the most common anorectal disorders, including hemorrhoids, anal fissures, fecal incontinence, proctalgia fugax, excessive perineal descent, and pruritus ani, and provides guidelines on comprehensive evaluation and management.
View Article and Find Full Text PDFGastroenterol Hepatol (N Y)
October 2013
Dr Islam and Dr Patel are gastroenterology fellows at the Mayo Clinic in Scottsdale, Arizona, where Dr Lam-Himlin is an assistant professor of laboratory medicine and pathology in the Department of Pathology and Dr Nguyen is an associate professor of medicine in the Division of Gastroenterology.
The increasing use of endoscopy has led to more discernable abnormalities in the stomach, including polyps. Gastric polyps encompass a spectrum of pathologic conditions that can vary in histology, neoplastic potential, and management. Despite their high prevalence, there is a paucity of literature to support management and treatment decisions for endoscopists.
View Article and Find Full Text PDFEndoscopy has evolved in the past 4 decades to become an important tool in the diagnosis and management of many digestive diseases. Greater focus on endoscopic quality has highlighted the need to ensure competency among endoscopists. A joint task force of the American College of Gastroenterology and the American Society for Gastrointestinal Endoscopy has proposed several quality metrics to establish competence and help define areas of continuous quality improvement.
View Article and Find Full Text PDFJAAPA
February 2014
Howard E. Asaki and Gianni Moshero practice in the Department of Urology at the Mayo Clinic Hospital in Phoenix, Ariz. Melissa L. Stanton practices in the Division of Anatomic Pathology at the Mayo Clinic in Scottsdale, Ariz. Mitchell R. Humphreys practices in the Department of Urology at the Mayo Clinic Hospital in Phoenix, Ariz. The authors have indicated no relationships to disclose relating to the content of this article.
Xp11.2 translocation tumor is a rare but aggressive form of renal cell carcinoma that predominantly occurs in children but also may be found in young adults. Because this type of cancer is diagnosed via histologic and chromosomal analysis, clinicians should consider translocation tumor in the differential diagnosis of patients with renal lesions and gross hematuria.
View Article and Find Full Text PDFGastroenterol Hepatol (N Y)
July 2013
The authors are affiliated with the Mayo Clinic in Scottsdale, Arizona. Dr. Costilla is a Resident in the Department of Internal Medicine. Dr. Mayer is an Assistant Professor in the Division of Women's Health Internal Medicine. Dr. Crowell is a Professor and Dr. Foxx-Orenstein is an Associate Professor in the Division of Gastroenterology.
Fecal incontinence (FI) is a devastating disorder that is more prevalent than previously realized. FI is the involuntary loss of stool. Many factors contribute to the pathophysiology of FI, including advanced age, bowel irregularity, parity, and obesity.
View Article and Find Full Text PDFPatients and family members are overwhelmed by the diagnosis of cancer and often do not know where to look for answers, information on the treatment options, or community resources for support during the cancer journey. A unique relationship was forged with a patient and health education librarian at the Mayo Clinic in Arizona and an American Cancer Society navigator, which encouraged collaboration to better meet the informational and supportive healthcare needs of patients. This article addresses the background of the project, the steps taken to establish the relationship, space allocation, and need for confidentiality.
View Article and Find Full Text PDFGastroenterol Hepatol (N Y)
October 2012
Dr. Lacy is Section Chief of Gastroenterology and Hepatology and Dr. Levenick is a Gastroenterology Fellow in the Division of Gastroenterology and Hepatology at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire. Dr. Crowell is a Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic in Scottsdale, Arizona.
Chronic constipation and irritable bowel syndrome (IBS) are functional gastrointestinal disorders that significantly affect patients' quality of life. Chronic constipation and IBS are prevalent-1 2% of the US population meet the diagnostic criteria for IBS, and 1 5% meet the criteria for chronic constipation- and these conditions negatively impact the healthcare system from an economic perspective. Despite attempts at dietary modification, exercise, or use of over-the-counter medications, many patients have persistent symptoms.
View Article and Find Full Text PDFGastroenterol Hepatol (N Y)
October 2007
Dr. Li is a fellow at the Mayo Clinic in Scottsdale, Arizona, where Dr. Leighton serves as Chair of Gastroenterology and Hepatology, and Dr. Sharma is Professor of Medicine and Director of the Esophageal Clinic.
Historically, the evaluation of patients with obscure gastrointestinal bleeding (OGIB) has been often suboptimal, due to the limited ability to adequately image the small bowel. However, over the past several years, significant improvements have been made in small-bowel imaging techniques, both endoscopically and radiologically. Since the introduction of capsule endoscopy (CE) in particular, the diagnostic and therapeutic approaches to OGIB have improved significantly.
View Article and Find Full Text PDF